FLUTX
Price
$24.93
Change
-$0.24 (-0.95%)
Updated
Apr 16 closing price
Net Assets
667.6M
RMEBX
Price
$52.90
Change
-$0.68 (-1.27%)
Updated
Apr 16 closing price
Net Assets
97.76B
Ad is loading...

FLUTX vs RMEBX

Header iconFLUTX vs RMEBX Comparison
Open Charts FLUTX vs RMEBXBanner chart's image
Fidelity Advisor Stk Selec Lg Cp Val M
Price$24.93
Change-$0.24 (-0.95%)
VolumeN/A
Net Assets667.6M
American Funds American Mutual R2E
Price$52.90
Change-$0.68 (-1.27%)
VolumeN/A
Net Assets97.76B
FLUTX vs RMEBX Comparison Chart
Loading...
View a ticker or compare two or three
VS
FLUTX vs. RMEBX commentary
Apr 17, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is FLUTX is a Hold and RMEBX is a Buy.

Ad is loading...
FUNDAMENTALS
Fundamentals
RMEBX has more cash in the bank: 97.8B vs. FLUTX (668M). RMEBX pays higher dividends than FLUTX: RMEBX (1.18) vs FLUTX (0.68). FLUTX was incepted earlier than RMEBX: FLUTX (18 years) vs RMEBX (11 years). FLUTX (1.42) is less costly to investors than RMEBX (1.07). FLUTX is a more actively managed with annual turnover of: 70.00 vs. RMEBX (31.00). FLUTX has a lower initial minimum investment than RMEBX: FLUTX (0) vs RMEBX (250). RMEBX annual gain was more profitable for investors over the last year : 4.42 vs. FLUTX (-1.73). FLUTX (55.87) and RMEBX (53.54) have equivalent 5 years return.
FLUTXRMEBXFLUTX / RMEBX
Total Expense Ratio1.421.07133%
Annual Report Gross Expense Ratio1.421.07133%
Fund Existence18 years11 years-
Gain YTD-5.998-2.139280%
Front Load4%N/A-
Min. Initial Investment0250-
Min. Initial Investment IRAN/AN/A-
Net Assets668M97.8B1%
Annual Yield % from dividends0.681.1857%
Returns for 1 year-1.734.42-39%
Returns for 3 years1.236.4519%
Returns for 5 years55.8753.54104%
Returns for 10 years50.9955.0093%
View a ticker or compare two or three
Ad is loading...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
WBS44.360.92
+2.12%
Webster Financial Corp
URGN10.750.15
+1.42%
UroGen Pharma Ltd
PNFPP24.270.22
+0.92%
Pinnacle Financial Partners
STR15.550.09
+0.58%
Sitio Royalties Corp
GALT1.34N/A
N/A
Galectin Therapeutics